Back to
Brevan Howard Capital Management LP
TVTX
Showing 6 of 9 quarters
Position history for
Brevan Howard Capital Management LP's holdings in Travere Therapeutics, Inc.
No. Brevan Howard exited its TVTX (Travere Therapeutics) position in Q1 2026. Its Q4 2025 13F listed 29,067 shares worth $1.1M. Brevan Howard first reported TVTX in Q4 2023 and held it in 7 quarterly 13F filings.
Final Value
$0
Final Shares
0
Total Value Change
-$863,113
Total Shares Change
-61,695
Quarter-by-Quarter History
Other major holders of TVTX: Jupiter Topco LLC, BlackRock, Inc., FMR LLC, Janus Henderson Group Ltd.